INDIANA UNIVERSITY HEALTH
- Type
- Teaching hospital
- Where
- INDIANAPOLIS, IN
- Medicare CCN
- 150056
- Received
- $2,998,232 in 149 records, 2019 ($1,194,101 general, $1,804,131 research)
- Source
- CMS Open Payments search ↗
On this site
- Business registration: Indiana University Health, Inc. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Business registration: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Nonprofit contractor: INDIANA UNIVERSITY HEALTH Fuzzy (name and state)
- Federal award recipient: INDIANA UNIVERSITY HEALTH INC Fuzzy (name and state)
- Federal award recipient: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Lobbying client: INDIANA UNIVERSITY HEALTH INC Fuzzy (name and state)
- Lobbying client: INDIANA UNIVERSITY HEALTH INC Fuzzy (name and state)
- Lobbying client: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Lobbying client: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Lobbying registrant: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
- Nonprofit: INDIANA UNIVERSITY HEALTH INC Fuzzy (name and state)
- Patent assignee: Indiana University Health, Inc. Fuzzy (name and state)
- Trademark owner: INDIANA UNIVERSITY HEALTH, INC. Fuzzy (name and state)
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2019 | General payment | 61 | $1,194,101 |
| 2019 | Research payment | 88 | $1,804,131 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Research payment | 88 | $1,804,131 |
| Grant | 10 | $1,069,898 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 3 | $84,302 |
| Gift | 33 | $18,818 |
| Space rental or facility fees (teaching hospital only) | 2 | $7,075 |
| Royalty or License | 1 | $4,988 |
| Charitable Contribution | 1 | $4,253 |
| Consulting Fee | 2 | $2,400 |
| Education | 4 | $2,130 |
| Food and Beverage | 5 | $234 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2019-12-31 | AngioDynamics, Inc. | $1,000 | Education | In-kind items and services | Navigator Device, Vascular Access | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $850 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-31 | Medline Industries LP | $700 | Research payment | Cash or cash equivalent | PluroGel Exempt 50 g (7 jars) | 2019 | |
| 2019-12-31 | Zimmer Biomet Holdings, Inc. | $51 | Gift | In-kind items and services | Zimmer Biomet Instruments and Implants Device, General | 2019 | |
| 2019-12-17 | Dova Pharmaceuticals | $8,750 | Research payment | Cash or cash equivalent | Doptelet Drug, Hematology | Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of avatrombopag in subjec | 2019 |
| 2019-12-13 | Medtronic, Inc. | $7,244 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-12-12 | INSTRUMENTATION LABORATORY COMPANY | $1,200 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-12-11 | bioMerieux Inc | $28,739 | Research payment | Cash or cash equivalent | VIDAS Device, Diagnostic | BPar - Indiana U - VITEK 2 GN22 - 2018 | 2019 |
| 2019-12-11 | United Therapeutics Corporation | $6,809 | Research payment | Cash or cash equivalent | TYVASO Drug, PAH | AN OPEN-LABEL EXTENSION STUDY OF INHALED TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION DUE TO PARENCHYMAL LUNG DI | 2019 |
| 2019-12-11 | Corcept Therapeutics | $1,775 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-12-09 | Incyte Corporation | $42 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-12-09 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-12-09 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-12-09 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $448 | Gift | In-kind items and services | Video Accessories Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $230 | Gift | In-kind items and services | Video Accessories Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $230 | Gift | In-kind items and services | Video Accessories Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $184 | Gift | In-kind items and services | Camera Heads Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $184 | Gift | In-kind items and services | Camera Heads Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $184 | Gift | In-kind items and services | Camera Heads Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $171 | Gift | In-kind items and services | LENS Surgical Imaging System Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $154 | Gift | In-kind items and services | Werewolf System Device, Sports Med Resection | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $112 | Gift | In-kind items and services | Dyonics Powermini/Powermax Device, Sports Med Resection | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $112 | Gift | In-kind items and services | Dyonics Powermini/Powermax Device, Sports Med Resection | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $112 | Gift | In-kind items and services | Dyonics Powermini/Powermax Device, Sports Med Resection | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $73 | Gift | In-kind items and services | Video Accessories Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $51 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $51 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $51 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $50 | Gift | In-kind items and services | Other VideoArthroscopes Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $45 | Gift | In-kind items and services | Arthroscopic Cannulas & Trocars Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $37 | Gift | In-kind items and services | Video Accessories Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $20 | Gift | In-kind items and services | Arthroscopic Cannulas & Trocars Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $20 | Gift | In-kind items and services | Arthroscopic Cannulas & Trocars Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $16 | Gift | In-kind items and services | Arthroscopic Cannulas & Trocars Device, Sports Med Visualization | 2019 | |
| 2019-12-08 | Smith+Nephew, Inc. | $16 | Gift | In-kind items and services | Arthroscopic Cannulas & Trocars Device, Sports Med Visualization | 2019 | |
| 2019-12-05 | Roche Diagnostics Corporation | $6,327 | Gift | In-kind items and services | TD BenchMark Platforms Device, Tissue Diagnostics | 2019 | |
| 2019-12-02 | Hollister Incorporated | $63 | Food and Beverage | In-kind items and services | CERAPLUS Device, OSTOMY | 2019 | |
| 2019-11-22 | Cook Medical LLC | $400,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-11-22 | Cook Medical LLC | $150,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-11-22 | Cook Incorporated | $100 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-11-22 | Hollister Incorporated | $47 | Food and Beverage | In-kind items and services | CERAPLUS Device, OSTOMY | 2019 | |
| 2019-11-20 | bioMerieux Inc | $88,285 | Research payment | Cash or cash equivalent | ETEST Device, Diagnostic | BPar - Indiana U - Etest- 2019 | 2019 |
| 2019-11-20 | Corcept Therapeutics | $5,892 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-11-20 | Corcept Therapeutics | $3,175 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-11-20 | Corcept Therapeutics | $753 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-11-19 | bioMerieux Inc | $20,688 | Research payment | In-kind items and services | NEPHROCHECK TEST Device, Diagnostic | VIDAS NEPHROCHECK | 2019 |
| 2019-11-14 | Medtronic, Inc. | $15,672 | Research payment | Cash or cash equivalent | ACTIVA Device, Deep Brain Neurostimulation | PSR-DBS | 2019 |
| 2019-11-13 | Corcept Therapeutics | $1,027 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-11-11 | Artivion, Inc. | $5,460 | Research payment | Cash or cash equivalent | PerClot Device, Cardiology and Vascular Diseases | Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of Per | 2019 |
| 2019-11-06 | bioMerieux Inc | $11,475 | Research payment | Cash or cash equivalent | ETEST Device, Diagnostic | BPar - Indiana U - Etest- 2019 | 2019 |
| 2019-10-29 | Genentech, Inc. | $3,680 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | CARBOPLATIN PEMETREXED ATEZOLIZUMAB BEVACIZUMAB IN CHEMOTHERAPY & IMMUNOTHERAPY-NAVE NSCLC | 2019 |
| 2019-10-24 | Stryker Corporation | $20,808 | Research payment | Cash or cash equivalent | SAGE PRIMAFIT Device, MEDICAL | AN EXTERNAL FEMALE URINARY COLLECTION DEVICE A PROSPECTIVE, DESCRIPTIVE STUDY | 2019 |
| 2019-10-18 | FUJIFILM SonoSite, Inc. | $388 | Education | In-kind items and services | Edge/Edge II Ultrasound System Device, Medical Device | 2019 | |
| 2019-10-10 | Genentech, Inc. | $10,459 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | ATEZOLIZUMAB CHEMOTHERAPY IN ADVANCED UROTHELIAL CARCINOMA | 2019 |
| 2019-10-10 | Genentech, Inc. | $9,200 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | ATEZOLIZUMAB CHEMOTHERAPY IN ADVANCED UROTHELIAL CARCINOMA | 2019 |
| 2019-10-10 | Genentech, Inc. | $925 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | CARBOPLATIN PEMETREXED ATEZOLIZUMAB BEVACIZUMAB IN CHEMOTHERAPY & IMMUNOTHERAPY-NAVE NSCLC | 2019 |
| 2019-10-09 | Corcept Therapeutics | $19,317 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-09-27 | Olympus America Inc. | $82,067 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | In-kind items and services | EVIS EXERA Device, GI & Respiratory Products | 2019 | |
| 2019-09-24 | Biosense Webster, Inc. | $6,600 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Carto 3 System Device, Cardiology | 2019 | |
| 2019-09-20 | Medtronic, Inc. | $8,176 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-09-16 | Medline Industries LP | $14,537 | Research payment | Cash or cash equivalent | Cell will be exposed to injury via bulk electroporation | 2019 | |
| 2019-09-11 | United Therapeutics Corporation | $1,668 | Research payment | Cash or cash equivalent | TYVASO Drug, PAH | AN OPEN-LABEL EXTENSION STUDY OF INHALED TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION DUE TO PARENCHYMAL LUNG DI | 2019 |
| 2019-08-28 | United Therapeutics Corporation | $8,574 | Research payment | Cash or cash equivalent | TYVASO Drug, PAH | A MULTICENTER RANDOMIZED DOUBLE-BLINDED PLACEBO-CONTROLLED TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF INHALED TREPROST | 2019 |
| 2019-08-26 | Medtronic, Inc. | $12,885 | Research payment | Cash or cash equivalent | ACTIVA Device, Deep Brain Neurostimulation | PSR-DBS | 2019 |
| 2019-08-21 | Corcept Therapeutics | $2,289 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-08-19 | FUJIFILM SonoSite, Inc. | $515 | Education | In-kind items and services | Edge/Edge II Ultrasound System Device, Medical Device | 2019 | |
| 2019-08-16 | Medline Industries LP | $12,081 | Research payment | Cash or cash equivalent | Cell will be exposed to injury via bulk electroporation | 2019 | |
| 2019-08-15 | Zimmer Biomet Holdings, Inc. | $795 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-14 | United Therapeutics Corporation | $6,238 | Research payment | Cash or cash equivalent | TYVASO Drug, PAH | AN OPEN-LABEL EXTENSION STUDY OF INHALED TREPROSTINIL IN SUBJECTS WITH PULMONARY HYPERTENSION DUE TO PARENCHYMAL LUNG DI | 2019 |
| 2019-08-08 | Incyte Corporation | $42 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-08-08 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-08-08 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-08-08 | Incyte Corporation | $24 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-08-08 | Incyte Corporation | $0 | Research payment | Cash or cash equivalent | A Phase 2 Study of the JAK1, JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High Risk CRLF2 Rearr | 2019 | |
| 2019-08-01 | Zimmer Biomet Holdings, Inc. | $5,522 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-08-01 | Medtronic, Inc. | $1,000 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-07-29 | Medline Industries LP | $9,713 | Research payment | Cash or cash equivalent | Cell will be exposed to injury via bulk electroporation | 2019 | |
| 2019-07-26 | Artivion, Inc. | $1,300 | Research payment | Cash or cash equivalent | PerClot Device, Cardiology and Vascular Diseases | Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of Per | 2019 |
| 2019-07-24 | Corcept Therapeutics | $513 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-07-17 | Corcept Therapeutics | $2,336 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-07-17 | Corcept Therapeutics | $533 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-06-30 | Genentech, Inc. | $925 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | CARBOPLATIN PEMETREXED ATEZOLIZUMAB BEVACIZUMAB IN CHEMOTHERAPY & IMMUNOTHERAPY-NAVE NSCLC | 2019 |
| 2019-06-26 | FUJIFILM Healthcare Americas Corporation | $524 | Gift | In-kind items and services | ESD - Double Balloon Device, Medical Device | 2019 | |
| 2019-06-19 | Corcept Therapeutics | $2,100 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-06-19 | Corcept Therapeutics | $1,503 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-06-18 | Medline Industries LP | $12,647 | Research payment | Cash or cash equivalent | Cell will be exposed to injury via bulk electroporation | 2019 | |
| 2019-06-18 | Medline Industries LP | $3,806 | Research payment | Cash or cash equivalent | Cell will be exposed to injury via bulk electroporation | 2019 | |
| 2019-06-14 | Medtronic, Inc. | $5,136 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-06-14 | Mallinckrodt Enterprises LLC | $2,125 | Gift | Cash or cash equivalent | CELLEX PHOTOPHERESIS SYSTEM Device, CRITICAL CARE | 2019 | |
| 2019-06-12 | Hollister Incorporated | $25 | Food and Beverage | In-kind items and services | CERAPLUS Device, OSTOMY | 2019 | |
| 2019-06-07 | Hollister Incorporated | $54 | Food and Beverage | In-kind items and services | CERAPLUS Device, OSTOMY | 2019 | |
| 2019-05-31 | Medline Industries LP | $7,620 | Research payment | Cash or cash equivalent | Cell will be exposed to injury via bulk electroporation | 2019 | |
| 2019-05-17 | FUJIFILM SonoSite, Inc. | $226 | Education | In-kind items and services | Edge/Edge II Ultrasound System Device, Medical Device | 2019 | |
| 2019-05-16 | Medtronic, Inc. | $12,512 | Research payment | Cash or cash equivalent | ACTIVA Device, Deep Brain Neurostimulation | PSR-DBS | 2019 |
| 2019-05-15 | Cook Medical LLC | $210,775 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-05-15 | Corcept Therapeutics | $1,540 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-05-14 | Medtronic Vascular, Inc. | $1,250 | Research payment | Cash or cash equivalent | HeartWare HVAD Device, Ventricular Assist Devices | ThoracotomyLateral HW006 | 2019 |
| 2019-05-10 | APPLIED MEDICAL TECHNOLOGY INC | $4,988 | Royalty or License | Cash or cash equivalent | Bridle Device, Enteral | 2019 | |
| 2019-05-07 | FUJIFILM Healthcare Americas Corporation | $152 | Gift | In-kind items and services | ESD - Double Balloon Device, Medical Device | 2019 | |
| 2019-05-01 | Corcept Therapeutics | $219 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-04-29 | E.R. Squibb & Sons, L.L.C. | $410,617 | Research payment | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | 2016-ELI-0362 Monotherapy Anticoagulation To expedite Home treatment of venous thromboembolism MATH VTE | 2019 |
| 2019-04-29 | Hollister Incorporated | $44 | Food and Beverage | In-kind items and services | CERAPLUS Device, OSTOMY | 2019 | |
| 2019-04-15 | Artivion, Inc. | $42,289 | Research payment | Cash or cash equivalent | PerClot Device, Cardiology and Vascular Diseases | Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of Per | 2019 |
| 2019-04-11 | Cook Medical LLC | $100,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-04-11 | Cook Medical LLC | $100,000 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-04-11 | Cook Medical LLC | $99,526 | Grant | Cash or cash equivalent | 2019 | ||
| 2019-04-11 | Medtronic, Inc. | $9,064 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-04-11 | E.R. Squibb & Sons, L.L.C. | $1,600 | Research payment | Cash or cash equivalent | OPDIVO Biological, Oncology | Phase III RCC Monotherapy vs. everolimus ONO 4538-03 | 2019 |
| 2019-04-10 | Corcept Therapeutics | $5,327 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-03-31 | AstraZeneca Pharmaceuticals LP | $4,253 | Charitable Contribution | Cash or cash equivalent | 2019 | ||
| 2019-03-27 | Corcept Therapeutics | $2,269 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-03-26 | Olympus America Inc. | $4 | Gift | In-kind items and services | Olympus Hemostasis Devices Device, EndoTherapy Products | 2019 | |
| 2019-03-25 | Medtronic, Inc. | $375 | Research payment | Cash or cash equivalent | ACTIVA Device, Deep Brain Neurostimulation | PSR-DBS | 2019 |
| 2019-03-25 | Medtronic, Inc. | $375 | Research payment | Cash or cash equivalent | Attain Device, Leads | PSR-CVG | 2019 |
| 2019-03-13 | bioMerieux Inc | $15,389 | Research payment | Cash or cash equivalent | VIDAS Device, Diagnostic | SM-Indiana-VIDAS B2707 PCT2019 | 2019 |
| 2019-03-13 | Corcept Therapeutics | $960 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-03-13 | Corcept Therapeutics | $910 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-03-13 | Corcept Therapeutics | $700 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-03-13 | Corcept Therapeutics | $77 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-03-12 | bioMerieux Inc | $588,116 | Research payment | In-kind items and services | VITEK2 Device, Diagnostic | GN22 | 2019 |
| 2019-03-08 | E.R. Squibb & Sons, L.L.C. | $15,426 | Research payment | Cash or cash equivalent | ELIQUIS Drug, Cardiovascular | Phase III Cardiac Study - pediatric | 2019 |
| 2019-03-07 | Medtronic Vascular, Inc. | $1,250 | Research payment | Cash or cash equivalent | HeartWare HVAD Device, Ventricular Assist Devices | ThoracotomyLateral HW006 | 2019 |
| 2019-03-06 | Corcept Therapeutics | $22,143 | Research payment | Cash or cash equivalent | CORT125134-452 | 2019 | |
| 2019-03-06 | E.R. Squibb & Sons, L.L.C. | $14,000 | Research payment | Cash or cash equivalent | OPDIVO Biological, Oncology | Phase 1 study of Nivolumab in recurrent small cell lung cancer | 2019 |
| 2019-03-01 | E.R. Squibb & Sons, L.L.C. | $6,203 | Research payment | Cash or cash equivalent | OPDIVO Biological, Oncology | Phase III Multiple Myeloma 3L Combo nivo - elo | 2019 |
| 2019-02-22 | APPLIED MEDICAL TECHNOLOGY INC | $475 | Space rental or facility fees (teaching hospital only) | Cash or cash equivalent | Bridle Device, Enteral | 2019 | |
| 2019-02-20 | Corcept Therapeutics | $9,072 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-02-20 | Corcept Therapeutics | $2,643 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-02-20 | Medtronic Vascular, Inc. | $2,056 | Research payment | Cash or cash equivalent | HeartWare HVAD Device, Ventricular Assist Devices | ThoracotomyLateral HW006 | 2019 |
| 2019-02-20 | Corcept Therapeutics | $1,500 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-02-20 | Corcept Therapeutics | $998 | Research payment | Cash or cash equivalent | CORT125134-455 | 2019 | |
| 2019-02-18 | Medline Industries LP | $1,434 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Reprocessed Instruments Medical Supply, Reprocessing | 2019 | |
| 2019-02-18 | Medline Industries LP | $801 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Medical Supply, Reprocessing | 2019 | |
| 2019-02-15 | Medtronic, Inc. | $12,527 | Research payment | Cash or cash equivalent | ACTIVA Device, Deep Brain Neurostimulation | PSR-DBS | 2019 |
| 2019-02-15 | Zimmer Biomet Holdings, Inc. | $3,180 | Grant | Cash or cash equivalent | Grants Device, General | 2019 | |
| 2019-02-13 | Medtronic Vascular, Inc. | $1,250 | Research payment | Cash or cash equivalent | HeartWare HVAD Device, Ventricular Assist Devices | ThoracotomyLateral HW006 | 2019 |
| 2019-02-06 | Genentech, Inc. | $10,459 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | ATEZOLIZUMAB CHEMOTHERAPY IN ADVANCED UROTHELIAL CARCINOMA | 2019 |
| 2019-02-06 | Genentech, Inc. | $9,200 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | ATEZOLIZUMAB CHEMOTHERAPY IN ADVANCED UROTHELIAL CARCINOMA | 2019 |
| 2019-02-04 | E.R. Squibb & Sons, L.L.C. | $6,973 | Research payment | Cash or cash equivalent | OPDIVO Biological, Oncology | Phase II Sequential Ipi - Anti-PD-1 | 2019 |
| 2019-02-04 | Medtronic Vascular, Inc. | $1,250 | Research payment | Cash or cash equivalent | HeartWare HVAD Device, Ventricular Assist Devices | ThoracotomyLateral HW006 | 2019 |
| 2019-01-29 | Genentech, Inc. | $17,157 | Research payment | Cash or cash equivalent | TECENTRIQ Biological, BioOncology | ATEZOLIZUMAB CHEMOTHERAPY IN ADVANCED UROTHELIAL CARCINOMA | 2019 |
| 2019-01-24 | KARL STORZ Endoscopy-America | $14 | Gift | In-kind items and services | NEURO-FIBERSCOPE, 3.7 X 34 Device, NEUROSURGERY | 2019 | |
| 2019-01-18 | BioFire Diagnostics, LLC | $677 | Gift | In-kind items and services | BioFire FilmArray Pneumonia 30 Pouch Kit (RFIT-ASY-0144) Device, Clinical Diagnostics | 2019 | |
| 2019-01-17 | Olympus America Inc. | $2,280 | Gift | In-kind items and services | 2019 | ||
| 2019-01-17 | INSTRUMENTATION LABORATORY COMPANY | $1,200 | Consulting Fee | Cash or cash equivalent | 2019 | ||
| 2019-01-16 | bioMerieux Inc | $187,141 | Research payment | In-kind items and services | VITEK2 Device, Diagnostic | GP20 | 2019 |
| 2019-01-14 | Artivion, Inc. | $2,632 | Research payment | Cash or cash equivalent | PerClot Device, Cardiology and Vascular Diseases | Prospective, Multicenter, Multidisciplinary, Controlled Clinical Investigation Evaluating the Safety and Efficacy of Per | 2019 |
| 2019-01-08 | FUJIFILM SonoSite, Inc. | $3,250 | Gift | Cash or cash equivalent | S II Ultrasound System Device, Medical Device | 2019 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Indianapolis city, IN, county Marion County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Indianapolis city, IN | County Marion County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 885,860 | 975,809 | 6,851,073 |
| Population, 2020 census P1 | 887,642 | 977,203 | 6,785,528 |
| Median age B01002 | 34.3 | 34.4 | 38.1 |
| Under 18 B01001 | 24.8% | 25.0% | 23.3% |
| 65 and over B01001 | 13.1% | 13.2% | 16.8% |
| Households B11001 | 362,961 | 400,432 | 2,716,009 |
| Foreign born B05002 | 12.7% | 12.6% | 6.3% |
| Median household income B19013 | $66,219 | $66,346 | $71,957 |
| Median family income B19113 | $82,766 | $83,024 | $90,767 |
| Per capita income B19301 | $37,680 | $37,704 | $38,351 |
| Poverty rate B17001 | 15.8% | 15.3% | 12.3% |
| Unemployment rate B23025 | 5.1% | 5.0% | 4.3% |
| Civilian labor force B23025 | 472,847 | 520,799 | 3,472,016 |
| Mean commute (minutes) B08013 | 24.6 | 24.5 | 24.1 |
| Bachelor's degree or higher B15003 | 34.9% | 34.8% | 29.5% |
| Housing units B25001 | 401,428 | 441,040 | 2,976,568 |
| Owner-occupied B25003 | 56.0% | 56.5% | 70.6% |
| Renters B25003 | 44.0% | 43.5% | 29.4% |
| Median home value B25077 | $224,800 | $224,000 | $218,200 |
| Median gross rent B25064 | $1,156 | $1,153 | $1,062 |
| White, not Hispanic B03002 | 48.9% | 49.5% | 75.4% |
| Black B03002 | 27.6% | 27.1% | 9.1% |
| Hispanic or Latino B03002 | 13.8% | 13.8% | 8.6% |
| Asian B03002 | 4.2% | 4.0% | 2.6% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Indianapolis city, IN.
Comments